ZSCALER INC (ZS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ZS • US98980G1022

174.34 USD
+4.16 (+2.44%)
At close: Feb 10, 2026
177 USD
+2.66 (+1.53%)
After Hours: 2/10/2026, 8:00:02 PM
Fundamental Rating

4

Overall ZS gets a fundamental rating of 4 out of 10. We evaluated ZS against 277 industry peers in the Software industry. The financial health of ZS is average, but there are quite some concerns on its profitability. ZS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ZS was profitable.
  • ZS had a positive operating cash flow in the past year.
  • ZS had negative earnings in each of the past 5 years.
  • ZS had a positive operating cash flow in each of the past 5 years.
ZS Yearly Net Income VS EBIT VS OCF VS FCFZS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • ZS has a Return On Assets of -0.63%. This is comparable to the rest of the industry: ZS outperforms 54.15% of its industry peers.
  • ZS has a Return On Equity of -2.07%. This is comparable to the rest of the industry: ZS outperforms 56.32% of its industry peers.
Industry RankSector Rank
ROA -0.63%
ROE -2.07%
ROIC N/A
ROA(3y)-2.49%
ROA(5y)-6.57%
ROE(3y)-11.58%
ROE(5y)-30.47%
ROIC(3y)N/A
ROIC(5y)N/A
ZS Yearly ROA, ROE, ROICZS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • ZS's Gross Margin of 76.65% is fine compared to the rest of the industry. ZS outperforms 70.76% of its industry peers.
  • ZS's Gross Margin has been stable in the last couple of years.
  • ZS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.23%
ZS Yearly Profit, Operating, Gross MarginsZS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

5

2. Health

2.1 Basic Checks

  • ZS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ZS has more shares outstanding than it did 1 year ago.
  • ZS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ZS has a worse debt to assets ratio.
ZS Yearly Shares OutstandingZS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ZS Yearly Total Debt VS Total AssetsZS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • ZS has an Altman-Z score of 4.15. This indicates that ZS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.15, ZS is in the better half of the industry, outperforming 72.92% of the companies in the same industry.
  • ZS has a debt to FCF ratio of 2.00. This is a good value and a sign of high solvency as ZS would need 2.00 years to pay back of all of its debts.
  • ZS's Debt to FCF ratio of 2.00 is fine compared to the rest of the industry. ZS outperforms 67.15% of its industry peers.
  • ZS has a Debt/Equity ratio of 0.86. This is a neutral value indicating ZS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ZS (0.86) is worse than 73.29% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for ZS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 2
Altman-Z 4.15
ROIC/WACCN/A
WACC10.89%
ZS Yearly LT Debt VS Equity VS FCFZS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that ZS should not have too much problems paying its short term obligations.
  • ZS has a Current ratio (1.82) which is comparable to the rest of the industry.
  • ZS has a Quick Ratio of 1.82. This is a normal value and indicates that ZS is financially healthy and should not expect problems in meeting its short term obligations.
  • ZS has a Quick ratio (1.82) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
ZS Yearly Current Assets VS Current LiabilitesZS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

8

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.47% over the past year.
  • The Earnings Per Share has been growing by 68.71% on average over the past years. This is a very strong growth
  • Looking at the last year, ZS shows a very strong growth in Revenue. The Revenue has grown by 23.24%.
  • The Revenue has been growing by 44.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.47%
EPS 3Y68.14%
EPS 5Y68.71%
EPS Q2Q%24.68%
Revenue 1Y (TTM)23.24%
Revenue growth 3Y34.82%
Revenue growth 5Y44.03%
Sales Q2Q%25.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.81% on average over the next years. This is quite good.
  • ZS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.01% yearly.
EPS Next Y20.25%
EPS Next 2Y18.92%
EPS Next 3Y19.33%
EPS Next 5Y19.81%
Revenue Next Year23.95%
Revenue Next 2Y21.61%
Revenue Next 3Y20.67%
Revenue Next 5Y20.01%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZS Yearly Revenue VS EstimatesZS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZS Yearly EPS VS EstimatesZS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 50.24, ZS can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as ZS.
  • Compared to an average S&P500 Price/Earnings ratio of 28.03, ZS is valued quite expensively.
  • ZS is valuated quite expensively with a Price/Forward Earnings ratio of 37.58.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ZS.
  • The average S&P500 Price/Forward Earnings ratio is at 27.97. ZS is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 50.24
Fwd PE 37.58
ZS Price Earnings VS Forward Price EarningsZS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ZS.
  • 62.45% of the companies in the same industry are more expensive than ZS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 32.78
EV/EBITDA 2723.72
ZS Per share dataZS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ZS's earnings are expected to grow with 19.33% in the coming years.
PEG (NY)2.48
PEG (5Y)0.73
EPS Next 2Y18.92%
EPS Next 3Y19.33%

0

5. Dividend

5.1 Amount

  • ZS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZSCALER INC

NASDAQ:ZS (2/10/2026, 8:00:02 PM)

After market: 177 +2.66 (+1.53%)

174.34

+4.16 (+2.44%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25
Earnings (Next)02-26
Inst Owners55.76%
Inst Owner Change0.14%
Ins Owners35.42%
Ins Owner Change-0.48%
Market Cap27.80B
Revenue(TTM)2.83B
Net Income(TTM)-41.04M
Analysts81.79
Price Target326.91 (87.51%)
Short Float %6.73%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.32%
Min EPS beat(2)8.25%
Max EPS beat(2)8.4%
EPS beat(4)4
Avg EPS beat(4)8.61%
Min EPS beat(4)8.25%
Max EPS beat(4)9.41%
EPS beat(8)8
Avg EPS beat(8)16.65%
EPS beat(12)12
Avg EPS beat(12)18.75%
EPS beat(16)16
Avg EPS beat(16)20.08%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-1.11%
Revenue beat(4)0
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-1.22%
Max Revenue beat(4)-1.03%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)7
Avg Revenue beat(12)0.3%
Revenue beat(16)11
Avg Revenue beat(16)0.65%
PT rev (1m)-2.11%
PT rev (3m)-1.44%
EPS NQ rev (1m)0.48%
EPS NQ rev (3m)1.36%
EPS NY rev (1m)0.42%
EPS NY rev (3m)4.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 50.24
Fwd PE 37.58
P/S 9.81
P/FCF 32.78
P/OCF 25.52
P/B 14.02
P/tB 35.99
EV/EBITDA 2723.72
EPS(TTM)3.47
EY1.99%
EPS(NY)4.64
Fwd EY2.66%
FCF(TTM)5.32
FCFY3.05%
OCF(TTM)6.83
OCFY3.92%
SpS17.77
BVpS12.43
TBVpS4.84
PEG (NY)2.48
PEG (5Y)0.73
Graham Number31.15
Profitability
Industry RankSector Rank
ROA -0.63%
ROE -2.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.65%
FCFM 29.93%
ROA(3y)-2.49%
ROA(5y)-6.57%
ROE(3y)-11.58%
ROE(5y)-30.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.4%
GM growth 5Y-0.23%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 2
Debt/EBITDA 191.34
Cap/Depr 176.38%
Cap/Sales 8.52%
Interest Coverage N/A
Cash Conversion 12262.5%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 4.15
F-Score4
WACC10.89%
ROIC/WACCN/A
Cap/Depr(3y)212%
Cap/Depr(5y)195.75%
Cap/Sales(3y)8.71%
Cap/Sales(5y)8.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.47%
EPS 3Y68.14%
EPS 5Y68.71%
EPS Q2Q%24.68%
EPS Next Y20.25%
EPS Next 2Y18.92%
EPS Next 3Y19.33%
EPS Next 5Y19.81%
Revenue 1Y (TTM)23.24%
Revenue growth 3Y34.82%
Revenue growth 5Y44.03%
Sales Q2Q%25.5%
Revenue Next Year23.95%
Revenue Next 2Y21.61%
Revenue Next 3Y20.67%
Revenue Next 5Y20.01%
EBIT growth 1Y-20.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.97%
EBIT Next 3Y33.54%
EBIT Next 5YN/A
FCF growth 1Y83.29%
FCF growth 3Y46.46%
FCF growth 5Y92.49%
OCF growth 1Y83.19%
OCF growth 3Y44.56%
OCF growth 5Y65.09%

ZSCALER INC / ZS FAQ

Can you provide the ChartMill fundamental rating for ZSCALER INC?

ChartMill assigns a fundamental rating of 4 / 10 to ZS.


Can you provide the valuation status for ZSCALER INC?

ChartMill assigns a valuation rating of 2 / 10 to ZSCALER INC (ZS). This can be considered as Overvalued.


How profitable is ZSCALER INC (ZS) stock?

ZSCALER INC (ZS) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ZSCALER INC?

The Earnings per Share (EPS) of ZSCALER INC (ZS) is expected to grow by 20.25% in the next year.